PatientsVille.com Logo

PatientsVille

Karvea Side Effects

Common Karvea Side Effects


The most commonly reported Karvea side effects (click to view or check a box to report):

Renal Failure Acute (7)
Hypotension (6)
Hyperkalaemia (6)
Hyponatraemia (5)
Dizziness (5)
Myalgia (4)
Suicide Attempt (4)
Bradycardia (4)
Tinnitus (4)
Overdose (4)
Angina Pectoris (3)
Blood Sodium Decreased (3)
Angioneurotic Oedema (3)
Atrial Fibrillation (3)
Mobility Decreased (3)
Hypertensive Crisis (3)
Nodal Arrhythmia (3)
Somnolence (3)
Syncope (3)
Pain In Extremity (3)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Karvea Side Effects Reported to FDA

The following Karvea reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Karvea on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Pancreatitis Acute
This is a report of a 71-year-old male patient (weight: NA) from IT, suffering from the following symptoms/conditions: hypertension, who was treated with Karvea (dosage: NA, start time: Jan 01, 2013), combined with:
  • Metformin Hydrochloride
  • Lansoprazole
  • Torvast
  • Cardirene
  • Altiazem
and developed a serious reaction and side effect(s). The consumer presented with:
  • Pancreatitis Acute
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Karvea treatment in male patients, resulting in pancreatitis acute side effect. The patient was hospitalized.

Syncope
This report suggests a potential Karvea Syncope side effect(s) that can have serious consequences. A 80-year-old female patient (weight: NA) from IT was diagnosed with the following symptoms/conditions: NA and used Karvea (dosage: NA) starting Oct 07, 2012. Soon after starting Karvea the patient began experiencing various side effects, including:
  • Syncope
Drugs used concurrently:
  • Lorazepam
  • Eutirox
Although Karvea demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as syncope, may still occur.

Psychomotor Retardation, Hypoglycaemia
This Psychomotor Retardation, Hypoglycaemia problem was reported by a physician from IT. A 80-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Jan 01, 2013 this consumer started treatment with Karvea (dosage: Strength: 75 Mg). The following drugs were being taken at the same time:
  • Madopar
  • Torvast (Strength: 10 Mg)
  • Delecit (Strength: 400 Mg)
  • Exemestane (Strength: 25 Mg)
  • Lantus
  • Humalog
  • Pentoxifylline
When commencing Karvea, the patient experienced the following unwanted symptoms/side effects:
  • Psychomotor Retardation
  • Hypoglycaemia
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as psychomotor retardation, may become evident only after a product is in use by the general population.

Blood Sodium Decreased, Syncope
This is a report of a 70-year-old female patient (weight: NA) from DE. The patient developed the following symptoms/conditions: hypertension and was treated with Karvea (dosage: NA) starting NS. Concurrently used drugs:
  • Eferox (Eferox 50 (l-thyroxine).)
Soon after that, the consumer experienced the following side effects:
  • Blood Sodium Decreased
  • Syncope
The patient was hospitalized. This opens a possibility that Karvea treatment could cause the above reactions, including blood sodium decreased, and some female subjects may be more susceptible.


Palpitations, Dyspnoea, Cough, Flushing, Dysgeusia
A 72-year-old female patient (weight: NA) from DE with the following symptoms/conditions: hypertension started Karvea treatment (dosage: Central Pharmaceutical Number: 0647629, [v09/2014], 98 Tablets] 150 Mg 1-0-0) on Jan 07, 2013. Soon after starting Karvea treatment, the subject experienced various side effects, including:
  • Palpitations
  • Dyspnoea
  • Cough
  • Flushing
  • Dysgeusia
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Karvea.

Nodal Arrhythmia, Renal Failure Acute, Toxicity To Various Agents, Conduction Disorder, Bradycardia
A 72-year-old female patient from IT (weight: NA) experienced symptoms, such as: hypertension,arrhythmia and was treated with Karvea(dosage: NA). The treatment was initiated on Jun 01, 2012. After that a consumer reported the following side effect(s):
  • Nodal Arrhythmia
  • Renal Failure Acute
  • Toxicity To Various Agents
  • Conduction Disorder
  • Bradycardia
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Karvea efficacy:
  • Lanoxin
  • Aldactone
  • Tareg
  • Lasix
  • Libradin
  • Congescor
  • Solosa
  • Nitroderm (Die Patches)
The patient was hospitalized.

Dizziness, Tinnitus
In this report, Karvea was administered for the following condition: hypertension.A 64-year-old male consumer from DE (weight: NA) started Karvea treatment (dosage: NA) on 201204.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Dizziness
  • Tinnitus
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Karvea treatment could be related to the listed above side effect(s).

Atrial Fibrillation, Hypokalaemia
This is a report of the following Karvea side effect(s):
  • Atrial Fibrillation
  • Hypokalaemia
A 63-year-old male patient from DE (weight: NA) presented with the following condition: hypertension and received a treatment with Karvea (dosage: 1df:1/3 Of A Tab Daily) starting: 201111.The following concurrently used drugs could have generated interactions:
  • Kalinor
  • Sotalex
This report suggests that a Karvea treatment could be associated with the listed above side effect(s).

Gastrointestinal Infection, Salpingo-oophoritis
This Karvea report was submitted by a 61-year-old female consumer from DE (weight: NA). The patient was diagnosed with: hypertension,salpingo-oophoritis,arrhythmia,toxic nodular goitre and Karvea was administered (dosage: Jun2004-may2011: 150 Mg, Tabs) starting: 1989. The consumer developed a set of symptoms:
  • Gastrointestinal Infection
  • Salpingo-oophoritis
Other drugs used simultaneously:
  • Azithromycin
  • Prajmalium Bitartrate (Tabs)
  • Levothyroxin (Tabs)
Those unexpected symptoms could be linked to a Karvea treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Renal Cell Carcinoma, Ovarian Mass, Joint Swelling, Oedema Peripheral
This is a report of a possible correlation between Karvea use and the following symptoms/side effect(s):
  • Renal Cell Carcinoma
  • Ovarian Mass
  • Joint Swelling
  • Oedema Peripheral
which could contribute to an assessment of Karvea risk profile.A female consumer from AUSTRALIA (weight: NA) was suffering from NA and was treated with Karvea (dosage: NA) starting NS.Other concurrent medications:
  • Pradaxa (220 Mg)
  • Crestor
  • Lasix
  • Protos


Acute Prerenal Failure, Nodal Arrhythmia
A 85-year-old female patient from ITALY (weight: NA) presented with the following symptoms: NA and after a treatment with Karvea (dosage: 300 Mg) experienced the following side effect(s):
  • Acute Prerenal Failure
  • Nodal Arrhythmia
The treatment was started on Jan 01, 2010. Karvea was used in combination with the following drugs:
  • Adalat (60 Mg)
  • Atorvastatin Calcium (10 Mg)
  • Kilor (1 Sachet)
  • Omapren (20 Mg)
  • Novolog Mix 70/30 (64 Iu)
  • Furosemide (80 Mg)
  • Allopurinol (100 Mg)
  • Nebivolol (5 Mg)
The patient was hospitalized.This report could alert potential Karvea consumers.

Haemoptysis, Pulmonary Alveolar Haemorrhage
In this report, a 39-year-old male patient from ITALY (weight: NA) was affected by a possible Karvea side effect.The patient was diagnosed with hypertension,cough. After a treatment with Karvea (dosage: Unk, start date: Mar 05, 2012), the patient experienced the following side effect(s):
  • Haemoptysis
  • Pulmonary Alveolar Haemorrhage
The following simultaneously used drugs could have led to this reaction:
  • Aspirin (Daily Dose 500 Mg)
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Karvea treatment.

Cerebrovascular Accident
This is a report of a male patient from AUSTRALIA (weight: NA), who used Karvea (dosage: NA) for a treatment of NA. After starting a treatment on Jun 29, 2006, the patient experienced the following side effect(s):
  • Cerebrovascular Accident
The following drugs could possibly have interacted with the Karvea treatment
  • Bicor
  • Lasix
  • Pradaxa (300 Mg)
  • Zyloprim
The patient was hospitalized.Taken together, these observations suggest that a Karvea treatment could be related to side effect(s), such as Cerebrovascular Accident.

Post Procedural Haemorrhage, Gastroenteritis Norovirus, Lymphocyte Percentage Decreased, Haematocrit Decreased, Red Blood Cell Count Decreased, Haemoglobin Decreased
This post procedural haemorrhage side effect was reported by a physician from GERMANY. A male patient (weight:NA) experienced the following symptoms/conditions: hypertension,diabetes mellitus. The patient was prescribed Karvea (dosage: Dose Not Provided), which was started on NS. Concurrently used drugs:
  • Berlinsulin H
  • Liprolog (Unit: E/ml)
  • Simvastatin (Dose Not Provided,scheduled As 1 X 1/2)
  • Trimineurin (Scheduling 1 X 1/2, 1 X 1/4.)
  • Xeloda (Dose Reduced In Response To Gastroenteritis Novovirus)
  • Digitoxin Tab
  • Memantine Hydrochloride (Dose Not Provided)
  • Oxaliplatin (Given On Days 1, 8, 15, 22 + 29. Last Dose Prior To 1st Sae 08/nov/2010. Actual Dose: 827mg)
When starting to take Karvea the consumer reported the following symptoms:
  • Post Procedural Haemorrhage
  • Gastroenteritis Norovirus
  • Lymphocyte Percentage Decreased
  • Haematocrit Decreased
  • Red Blood Cell Count Decreased
  • Haemoglobin Decreased
The patient was hospitalized. These side effects may potentially be related to Karvea.

Hyperkalaemia, Bradycardia
This is a Karvea Film-coated Tabs 150 Mg side effect report of a 88-year-old male patient (weight:NA) from IT, suffering from the following symptoms/conditions: NA, who was treated with Karvea Film-coated Tabs 150 Mg (dosage:1 Unit, start time: Apr 07, 2009), combined with:
  • Moduretic (1df:5mg Plus 50mg Tabs?int On 7apr11)
  • Carvedilol (Int On 7apr11)
  • Cordarone (Int On 7apr11)
  • Zyloric (1df:300 Units Nos?scored Tabs)
  • Cardioaspirin (Gastroresistant Tabs?1 Unit)
  • Cardura (1 Unit)
  • Casodex (Film Coated Oral Tabs:1 Unit)
, and developed a serious reaction and a hyperkalaemia side effect. The patient presented with:
  • Hyperkalaemia
  • Bradycardia
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Karvea Film-coated Tabs 150 Mg treatment in male patients suffering from NA, resulting in hyperkalaemia.

Gastroenteritis Norovirus, Post Procedural Haemorrhage
This report suggests a potential Karvea gastroenteritis norovirus side effect(s) that can have serious consequences. A male patient from GERMANY (weight:NA) was diagnosed with the following health condition(s): hypertension,rectal cancer and used Karvea (dosage: Dose Not Provided) starting NS. Soon after starting Karvea the patient began experiencing various side effects, including:
  • Gastroenteritis Norovirus
  • Post Procedural Haemorrhage
Drugs used concurrently:
  • Xeloda (Last Dose Prior To Sae 09 November 2010. Dose Reduced)
  • Oxaliplatin (Dose: 50 Mg/m2, On D1, 8, 15, 22 And 29.last Dose Prior To Sae 08 Nov 2010.actual Dose 827mg.)
  • Digitoxin Tab
  • Trimineurin (Scheduling 1 X 1/2, 1 X 1/4.)
  • Berlinsulin H
  • Memantine Hydrochloride (Dose Not Provided)
  • Simvastatin (Dose Not Provided,scheduled As 1 X 1/2)
The patient was hospitalized. Although Karvea demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as gastroenteritis norovirus, may still occur.


This death problem was reported by a physician from GERMANY. A 64-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Mar 02, 2009 a consumer started treatment with Karvea (dosage: 1/ Tablet Per Day). The following drugs/medications were being taken at the same time:
  • Levothyroxine Sodium
  • Ramipril
  • Torsemide
  • Protaphane
  • Radedorm
  • Aspirin
  • Tramadol Hcl (Daily Dose 150mg)
  • Omeprazole
When commencing Karvea, the patient experienced the following unwanted symptoms /side effects:
    Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as death, may become evident only after a product is in use by the general population.

    Lung Neoplasm, Presyncope
    This is a Karvea side effect report of a male patient (weight: NA) from AUSTRALIA. The patient developed the following symptoms/conditions: NA and was treated with Karvea (dosage: Unk) starting Jan 01, 1998. Concurrently used drugs:
    • Buprenorphine
    • Acetylsalicylic Acid Srt (Unk)
    • Pravastatin Sodium (Unk)
    • Nexium /01479303/ (Unk)
    • Buprenorphine
    • Buprenorphine (5 Mcg, Q1h)
    • Buprenorphine
    • Spiriva (Unk)
    Soon after that, the consumer experienced the following of symptoms:
    • Lung Neoplasm
    • Presyncope
    This opens a possibility that Karvea could cause lung neoplasm and that some male patients may be more susceptible.

    Blood Sodium Decreased
    A 83-year-old female patient (weight: NA) from AUSTRALIA with the following symptoms: hypertension started Karvea treatment (dosage: NA) on Jan 01, 2006. Soon after starting Karvea treatment, the consumer experienced several side effects, including:
    • Blood Sodium Decreased
    . Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Karvea side effects, such as blood sodium decreased.

    Respiratory Failure, Asthenia, Renal Failure Acute, Hepatic Failure
    This respiratory failure side effect was reported by a consumer or non-health professional from ITALY. A 79-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Karvea Tabs 300 Mg (dosage: 1 Df: 1 Unit), which was started on Jan 01, 2010. Concurrently used drugs:
    • Preterax (Preterax 2.5mg+0.625mg Tabs , 1 Unit/day.)
    • Humulin R
    • Novonorm
    • Imipenem
    • Metoprolol Tartrate
    • Permixon
    • Asa
    .When starting to take Karvea Tabs 300 Mg the consumer reported symptoms, such as:
    • Respiratory Failure
    • Asthenia
    • Renal Failure Acute
    • Hepatic Failure
    These side effects may potentially be related to Karvea Tabs 300 Mg. The patient was hospitalized.

    Intestinal Obstruction, Neoplasm Malignant
    This is a report of a male patient (weight: NA) from AUSTRALIA, suffering from the following symptoms/conditions: NA, who was treated with Karvea (dosage: NA, start time: Oct 01, 2008), combined with:
    • Frusemide
    • Cetuximab
    • Carvedilol
    • Clexane
    • Xeloda (Dosing 12000 Mg/m2/d. Form And Route Per Protocol.)
    • Xeloda (Cycle No.:13. Number Of Days Taken:14 Days)
    • Fluorouracil
    • Avastin
    and developed a serious reaction and side effect(s). The consumer presented with:
    • Intestinal Obstruction
    • Neoplasm Malignant
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Karvea treatment in male patients, resulting in intestinal obstruction side effect.

    Mobility Decreased, Cardiac Failure, Tinnitus, Angina Pectoris
    This report suggests a potential Karvea Tabs 150 Mg Mobility Decreased, Cardiac Failure, Tinnitus, Angina Pectoris side effect(s) that can have serious consequences. A 70-year-old female patient (weight: NA) from GERMANY was diagnosed with the following symptoms/conditions: hypertension and used Karvea Tabs 150 Mg (dosage: NA) starting Jan 01, 1998. Soon after starting Karvea Tabs 150 Mg the patient began experiencing various side effects, including:
    • Mobility Decreased
    • Cardiac Failure
    • Tinnitus
    • Angina Pectoris
    Drugs used concurrently: NA. Although Karvea Tabs 150 Mg demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as mobility decreased, may still occur.

    Angina Pectoris, Cardiac Failure, Mobility Decreased, Tinnitus
    This Angina Pectoris, Cardiac Failure, Mobility Decreased, Tinnitus problem was reported by a consumer or non-health professional from GERMANY. A 70-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hypertension. On Jan 01, 1998 this consumer started treatment with Karvea Tabs 150 Mg (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Karvea Tabs 150 Mg, the patient experienced the following unwanted symptoms/side effects:
    • Angina Pectoris
    • Cardiac Failure
    • Mobility Decreased
    • Tinnitus
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as angina pectoris, may become evident only after a product is in use by the general population.

    Angina Pectoris, Cardiac Failure, Left Ventricular Hypertrophy, Mobility Decreased, Tinnitus
    This is a report of a 70-year-old female patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: hypertension and was treated with Karvea Tabs 150 Mg (dosage: NA) starting Jan 01, 1998. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
    • Angina Pectoris
    • Cardiac Failure
    • Left Ventricular Hypertrophy
    • Mobility Decreased
    • Tinnitus
    This opens a possibility that Karvea Tabs 150 Mg treatment could cause the above reactions, including angina pectoris, and some female subjects may be more susceptible.

    Anaemia, Hepatitis Acute
    A 69-year-old male patient (weight: NA) from GERMANY with the following symptoms/conditions: hypertension started Karvea Tabs 300 Mg treatment (dosage: NA) on Aug 06, 2009. Soon after starting Karvea Tabs 300 Mg treatment, the subject experienced various side effects, including:
    • Anaemia
    • Hepatitis Acute
    Concurrently used drugs:
    • Spironolactone (Form Tablets; Hexal.)
    The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Karvea Tabs 300 Mg.

    1 of 4 



    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Karvea Side Effects

    Did You Have a Karvea Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Karvea for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective